Maternal Hormone Levels and Testicular Cancer Risk
Author Information
Author(s): Zhang Y, Graubard B I, Klebanoff M A, Ronckers C, Stanczyk F Z, Longnecker M P, McGlynn K A
Primary Institution: Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS
Hypothesis
Are maternal hormone levels associated with the risk of testicular germ cell cancer (TGCT) in different ethnic groups?
Conclusion
The study found little evidence to support the hypothesis that increased maternal estrogen levels are associated with increased risk of TGCT.
Supporting Evidence
- Black mothers had significantly higher estradiol levels in the first trimester.
- Black mothers had significantly higher levels of all testosterone and AFP in both trimesters.
- The ratios of sex hormones were significantly lower among black mothers.
Takeaway
This study looked at hormone levels in pregnant women and found that higher testosterone levels might actually be linked to a lower risk of testicular cancer in their sons.
Methodology
The study compared hormone levels in serum samples from 150 black and 150 white mothers during the first and third trimesters.
Potential Biases
Potential bias due to the retrospective nature of the study and reliance on stored samples.
Limitations
Hormone levels were measured on samples stored for roughly 40 years, which may affect accuracy.
Participant Demographics
150 black and 150 white mothers, with black mothers being younger and of lower socioeconomic status.
Statistical Information
P-Value
P=0.05 for estradiol levels in first trimester; P<0.001 for testosterone and AFP levels.
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website